Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies

التفاصيل البيبلوغرافية
العنوان:	Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM^®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies
المؤلفون:	Sánchez, Pedro^{Aff1, Aff2}, Álamo, Cecilio, Almendros, Marcos, Schlueter, Max, Tasoulas, Anastasios, Martínez, Javier^{Aff4, IDs1299102300464z_cor6}
المصدر:	Annals of General Psychiatry. 22(1)
قاعدة البيانات:	Springer Nature Journals

الوصف
تدمد:	1744859X
DOI:	10.1186/s12991-023-00464-z